Search

Your search keyword '"Schwartz, Stefan"' showing total 995 results

Search Constraints

Start Over You searched for: Author "Schwartz, Stefan" Remove constraint Author: "Schwartz, Stefan"
995 results on '"Schwartz, Stefan"'

Search Results

1. Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

2. Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols

7. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

8. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment

9. Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase.

17. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL

19. Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia

20. A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.

21. RNA elements that control human papillomavirus mRNA splicing-targets for therapy?

23. Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)

24. Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia

30. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia

33. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

34. Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials

36. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study

38. P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORLD TREATMENT AND OUTCOME IN SECONDARY CNS LYMPHOMA

39. P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM THE GMALL TRIAL 08/13

40. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

41. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia

43. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures

44. Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications

50. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Catalog

Books, media, physical & digital resources